Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticoagulation for Non-occlusive PVT in Cirrhosis
NCT02526303Withdrawn
- Sponsor
- Air Force Medical University
- Primary completion
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
Randomised, open-label trial of warfarin and nadroparin in portal vein thrombosis (PVT) (2 arms), sponsored by Air Force Medical University. Primary endpoint: Number of Participants With Portal Vein Recanalization as Assessed by Cummulative Rate at 2 years. Status: withdrawn.
02
Drugs
warfarinnadroparin
03
Conditions
portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT02526303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02526303.